The New Biomarkers Impacting Cancer Care
When my healthcare provider (HCP) told me I needed HER2 and BRCA testing, I nodded politely like I totally understood everything she was saying. But, in reality, I had no clue what...
Search fresh public links, source activity, and post angles for Biomarkers.
Fresh curated links around Biomarkers are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
When my healthcare provider (HCP) told me I needed HER2 and BRCA testing, I nodded politely like I totally understood everything she was saying. But, in reality, I had no clue what...
In the realm of neurodegenerative diseases, the precise and early diagnosis of dementia remains one of the most challenging hurdles for clinicians and researchers alike. Dementia,...
Discover how biomarker strategies are transforming oncology trials and accelerating precision medicine breakthroughs.
In a groundbreaking advancement for Alzheimer’s disease research, scientists have unveiled a novel method for measuring blood biomarkers associated with cognitive decline through r...
Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care. The post The Key Biomarkers Changin...
This ebook is designed to deliver both strategic insight and practical guidance. It opens with a White Paper informed by expert perspectives from senior translational leaders at le...
In a groundbreaking study published in Nature Communications, researchers at The University of Texas MD Anderson Cancer Center have unveiled a novel blood-based biomarker capable o...
"...these blood-based biomarkers could be truly transformative in developing treatments for this patient population."
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal can...
Why biomarker-driven oncology trials require new thinking across patient recruitment, assay development and regulatory strategy.
In the high-stakes world of neonatal care, the evaluation and management of sepsis in very low birth weight (VLBW) infants remains a critical challenge. Sepsis, a life-threatening...
In a groundbreaking advancement poised to reshape clinical obesity management, researchers have introduced a novel biomarker-centric framework that revolutionizes patient monitorin...
In a groundbreaking study poised to reshape the landscape of pancreatic cancer research, Chen, Lou, Guo, and colleagues have unveiled a sophisticated approach that links genetic mu...
Approximately a third of patients with pancreatic ductal adenocarcinoma do not have elevated or detectable levels of a biomarker commonly used to measure response to therapy.An AI...
Plus, why "normal" lab results aren't the same as healthy.
Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has returned or spread remains a major challenge for patients an...
In the ever-evolving landscape of medical diagnostics, the quest for precise, accessible, and non-invasive biomarkers has always been paramount, especially when it comes to metabol...
In the relentless quest to unravel the complexities of brain aging and neurodegenerative diseases, a groundbreaking study led by Li, Zhang, Li, and colleagues, published in Nature...
Scientists know that damage to microscopic blood vessels can provide an early warning sign of heart and kidney disease. But current methods for monitoring these tiny vessels are to...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.